Abstract
Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), front temporal dementia (FTD) and Huntington’s disease (HD show some clinical, morbid and molecular overlapping [1]. PD is one of the most common neurodegenerative disorders. Dopaminergic neurons in the substantia nigra pars compacta degenerate and die, which forms the basis of the disease [2]. As the disease intensifies with the passage of time, many people develop dementia, and other mental abilities in later stages [3]. Loss of dopaminergic neurons causes prominent and projecting symptoms like involuntary tremor, rigidity, postural instability, gait, speech problems and akinesia [4]. One accepted and efficient convention for generating dopaminergic neurons in vitro is the combination of several pharmacological compounds and molecules. A broad general evaluation of neurodegeneration is discussed in this article.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
